• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓系体细胞突变panel 检测在骨髓增殖性肿瘤中的应用。

Myeloid somatic mutation panel testing in myeloproliferative neoplasms.

机构信息

Myeloproliferative Neoplasms Working Party, Australasian Leukaemia and Lymphoma Group, Melbourne, Vic, Australia; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Department of Haematology and Genetic Pathology, Flinders University and Medical Centre, Adelaide, SA, Australia.

Myeloproliferative Neoplasms Working Party, Australasian Leukaemia and Lymphoma Group, Melbourne, Vic, Australia; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia.

出版信息

Pathology. 2021 Apr;53(3):339-348. doi: 10.1016/j.pathol.2021.01.003. Epub 2021 Mar 3.

DOI:10.1016/j.pathol.2021.01.003
PMID:33674147
Abstract

Myeloproliferative neoplasms are characterised by somatic mutations in pathways that regulate cell proliferation, epigenetic modifications, RNA splicing or DNA repair. Assessment of the mutational profile assists diagnosis and classification, but also aids assessment of prognosis, and may guide the use of emerging targeted therapies. The most practical way to provide information on numerous genetic variants is by using massively parallel sequencing, commonly in the form of disease specific next generation sequencing (NGS) panels. This review summarises the diagnostic and prognostic value of somatic mutation testing in Philadelphia-negative myeloproliferative neoplasms: polycythaemia vera, essential thrombocythaemia, primary myelofibrosis, chronic neutrophilic leukaemia, systemic mastocytosis, and chronic eosinophilic leukaemia. NGS panel testing is increasing in routine practice and promises to improve the accuracy and efficiency of pathological diagnosis and prognosis.

摘要

骨髓增殖性肿瘤的特征是调节细胞增殖、表观遗传修饰、RNA 剪接或 DNA 修复的途径中的体细胞突变。突变谱的评估有助于诊断和分类,也有助于评估预后,并可能指导新兴靶向治疗的应用。提供大量遗传变异信息的最实用方法是使用大规模平行测序,通常是以疾病特异性的下一代测序 (NGS) 面板的形式。本综述总结了体细胞突变检测在费城阴性骨髓增殖性肿瘤中的诊断和预后价值:真性红细胞增多症、特发性血小板增多症、原发性骨髓纤维化、慢性中性粒细胞白血病、系统性肥大细胞增多症和慢性嗜酸性粒细胞白血病。NGS 面板检测在常规实践中越来越普及,并有望提高病理诊断和预后的准确性和效率。

相似文献

1
Myeloid somatic mutation panel testing in myeloproliferative neoplasms.髓系体细胞突变panel 检测在骨髓增殖性肿瘤中的应用。
Pathology. 2021 Apr;53(3):339-348. doi: 10.1016/j.pathol.2021.01.003. Epub 2021 Mar 3.
2
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera.基于二代测序的28基因检测 panel 在骨髓增殖性肿瘤中的应用揭示了原发性血小板增多症、原发性骨髓纤维化和真性红细胞增多症中不同的突变模式。
Br J Haematol. 2016 Nov;175(3):419-426. doi: 10.1111/bjh.14269. Epub 2016 Jul 22.
3
[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].慢性骨髓增殖性疾病诊断的新方法——JAK2 突变检测
Orv Hetil. 2006 Nov 12;147(45):2175-9.
4
Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms.新一代测序重新定义了三阴性骨髓增殖性肿瘤的诊断。
Ann Hematol. 2022 Mar;101(3):705-708. doi: 10.1007/s00277-021-04561-5. Epub 2021 Sep 13.
5
Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing.费城阴性骨髓增殖性肿瘤:下一代测序时代的实验室检测。
Curr Hematol Malig Rep. 2019 Oct;14(5):376-385. doi: 10.1007/s11899-019-00534-8.
6
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.伴有钙网蛋白突变的骨髓增殖性肿瘤的独特临床特征。
Haematologica. 2014 Jul;99(7):1184-90. doi: 10.3324/haematol.2014.107482. Epub 2014 Jun 3.
7
Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.慢性骨髓增殖性疾病:酪氨酸激酶在发病机制、诊断及治疗中的作用
Pathobiology. 2007;74(2):81-8. doi: 10.1159/000101707.
8
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.CALR 和 CSF3R 突变概述及对世界卫生组织骨髓增殖性肿瘤诊断标准修订的建议。
Leukemia. 2014 Jul;28(7):1407-13. doi: 10.1038/leu.2014.35. Epub 2014 Jan 20.
9
The Calreticulin gene and myeloproliferative neoplasms.钙网蛋白基因与骨髓增殖性肿瘤
J Clin Pathol. 2016 Oct;69(10):841-5. doi: 10.1136/jclinpath-2016-203899. Epub 2016 Jun 28.
10
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives.骨髓增殖性肿瘤(MPN)的进展:诊断与治疗视角。
Cells. 2021 Dec 16;10(12):3551. doi: 10.3390/cells10123551.

引用本文的文献

1
Molecular landscape of non-driver genes in myeloproliferative neoplasms through 333 cancer genes panel: Insights to reveal in Pakistan.通过333个癌症基因检测分析骨髓增殖性肿瘤中非驱动基因的分子图谱:巴基斯坦的研究启示
BMC Med Genomics. 2025 Aug 4;18(1):125. doi: 10.1186/s12920-025-02159-8.
2
Evaluation of New Generation Sequencing (NGS)-Based Somatic Gene Variations and Real-Time Polymerase Chain Reaction (PCR)-Based Gene Fusions in Elderly and Young Acute Leukemia Patients: A Retrospective View.老年和青年急性白血病患者中基于新一代测序(NGS)的体细胞基因变异及基于实时聚合酶链反应(PCR)的基因融合评估:一项回顾性研究
J Pers Med. 2024 Jan 26;14(2):140. doi: 10.3390/jpm14020140.
3
Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of -Negative Myeloproliferative Neoplasm.
分子生物学对 - 阴性骨髓增殖性肿瘤的诊断、预后和治疗管理的影响。
Cells. 2022 Dec 27;12(1):105. doi: 10.3390/cells12010105.
4
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.基因组分析在髓系肿瘤和急性白血病中的临床决策应用。
Blood. 2022 Nov 24;140(21):2228-2247. doi: 10.1182/blood.2022015853.
5
Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing.骨髓增殖性肿瘤的遗传图谱,重点关注分子诊断实验室检测
Life (Basel). 2021 Oct 30;11(11):1158. doi: 10.3390/life11111158.
6
The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms.CALR 阳性骨髓增殖性肿瘤的当代治疗方法。
Int J Mol Sci. 2021 Mar 25;22(7):3371. doi: 10.3390/ijms22073371.